This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: The Innovative Contributions of Stacey Lindsley
Introduction
Stacey Lindsley is a notable inventor based in Schwenksville, PA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of Alzheimer's disease. Her work focuses on developing compounds that inhibit the beta-secretase enzyme, which plays a crucial role in the progression of this debilitating condition.
Latest Patents
Stacey holds 1 patent for her invention titled "Macrocyclic tertiary amine beta-secretase inhibitors for the treatment of Alzheimer's disease." This patent describes macrocyclic tertiary amine compounds that are effective inhibitors of the beta-secretase enzyme. The invention also includes pharmaceutical compositions that utilize these compounds for treating diseases associated with beta-secretase.
Career Highlights
Stacey Lindsley is affiliated with Merck Sharp & Dohme Corp., a leading global healthcare company. Her work at Merck has allowed her to contribute to groundbreaking research and development in the pharmaceutical industry.
Collaborations
Throughout her career, Stacey has collaborated with esteemed colleagues, including Keith P Moore and Shawn J Stachel. These collaborations have further enhanced her research and innovation in the field.
Conclusion
Stacey Lindsley's contributions to the development of beta-secretase inhibitors represent a significant advancement in the treatment of Alzheimer's disease. Her innovative work continues to impact the pharmaceutical industry positively.